Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Hematopoietic Stem Cell Transplantation | 11 | 2020 | 2426 | 1.63 | Why? |
Cannabis | 2 | 2018 | 284 | 1.03 | Why? |
Transplantation Conditioning | 3 | 2020 | 323 | 0.91 | Why? |
Vancomycin-Resistant Enterococci | 2 | 2018 | 104 | 0.82 | Why? |
Gram-Positive Bacterial Infections | 2 | 2018 | 323 | 0.67 | Why? |
Medical Marijuana | 1 | 2017 | 55 | 0.65 | Why? |
Recreation | 1 | 2017 | 143 | 0.64 | Why? |
Treatment Refusal | 1 | 2018 | 211 | 0.62 | Why? |
Measles-Mumps-Rubella Vaccine | 1 | 2019 | 282 | 0.62 | Why? |
Legionnaires' Disease | 1 | 2017 | 108 | 0.62 | Why? |
Caliciviridae Infections | 1 | 2017 | 229 | 0.54 | Why? |
Norovirus | 1 | 2017 | 294 | 0.51 | Why? |
Neoplasms | 8 | 2021 | 17251 | 0.50 | Why? |
Measles | 1 | 2019 | 608 | 0.45 | Why? |
Mycoses | 1 | 2017 | 589 | 0.42 | Why? |
Bacteremia | 2 | 2018 | 1372 | 0.41 | Why? |
Antifungal Agents | 2 | 2017 | 1828 | 0.40 | Why? |
Vaccination Coverage | 1 | 2018 | 1249 | 0.38 | Why? |
Washington | 6 | 2020 | 1722 | 0.37 | Why? |
Family Characteristics | 1 | 2018 | 2551 | 0.35 | Why? |
Hematologic Neoplasms | 2 | 2020 | 2105 | 0.34 | Why? |
Transplantation, Homologous | 3 | 2018 | 757 | 0.33 | Why? |
Influenza, Human | 3 | 2019 | 10779 | 0.30 | Why? |
Diarrhea | 1 | 2017 | 2743 | 0.29 | Why? |
Immunocompromised Host | 2 | 2019 | 5150 | 0.25 | Why? |
Palliative Care | 1 | 2017 | 2665 | 0.24 | Why? |
Influenza Vaccines | 1 | 2018 | 2941 | 0.24 | Why? |
Organ Transplantation | 1 | 2017 | 2616 | 0.23 | Why? |
Peripheral Blood Stem Cell Transplantation | 2 | 2018 | 86 | 0.22 | Why? |
Cytomegalovirus Infections | 2 | 2018 | 667 | 0.22 | Why? |
Mucorales | 2 | 2019 | 92 | 0.22 | Why? |
Transplant Recipients | 1 | 2017 | 4982 | 0.21 | Why? |
Bone Marrow Transplantation | 2 | 2020 | 343 | 0.20 | Why? |
Laundry Service, Hospital | 1 | 2019 | 10 | 0.20 | Why? |
Bedding and Linens | 1 | 2019 | 53 | 0.19 | Why? |
Legionella | 1 | 2017 | 91 | 0.17 | Why? |
Pneumonia | 1 | 2017 | 5652 | 0.16 | Why? |
Cord Blood Stem Cell Transplantation | 1 | 2018 | 143 | 0.16 | Why? |
Sexism | 1 | 2021 | 278 | 0.16 | Why? |
Hepatitis C | 1 | 2008 | 1514 | 0.16 | Why? |
Mucosal-Associated Invariant T Cells | 1 | 2017 | 170 | 0.15 | Why? |
Cytomegalovirus | 2 | 2018 | 600 | 0.14 | Why? |
Vancomycin | 1 | 2018 | 328 | 0.14 | Why? |
Caregivers | 2 | 2021 | 3112 | 0.14 | Why? |
Pregnancy Outcome | 1 | 2008 | 3803 | 0.14 | Why? |
Antigens, Bacterial | 1 | 2017 | 330 | 0.14 | Why? |
Allografts | 1 | 2017 | 761 | 0.13 | Why? |
Antimicrobial Stewardship | 2 | 2019 | 931 | 0.13 | Why? |
Graft vs Host Disease | 1 | 2017 | 501 | 0.13 | Why? |
Invasive Fungal Infections | 1 | 2017 | 274 | 0.13 | Why? |
Anti-Bacterial Agents | 4 | 2019 | 10083 | 0.13 | Why? |
Triazoles | 1 | 2017 | 440 | 0.13 | Why? |
Influenza A Virus, H3N2 Subtype | 1 | 2017 | 572 | 0.12 | Why? |
Clinical Trials as Topic | 2 | 2021 | 7330 | 0.11 | Why? |
Blood Transfusion | 1 | 2020 | 1399 | 0.11 | Why? |
Patients | 1 | 2018 | 1167 | 0.11 | Why? |
Patient Selection | 2 | 2021 | 4560 | 0.10 | Why? |
Disinfection | 2 | 2020 | 2912 | 0.09 | Why? |
United States | 6 | 2020 | 46150 | 0.09 | Why? |
Respiratory Syncytial Virus Infections | 1 | 2018 | 1234 | 0.09 | Why? |
Humans | 28 | 2021 | 930598 | 0.09 | Why? |
Bronchoalveolar Lavage Fluid | 1 | 2017 | 2309 | 0.09 | Why? |
Academic Medical Centers | 1 | 2020 | 3088 | 0.09 | Why? |
Cost of Illness | 1 | 2018 | 1903 | 0.08 | Why? |
Middle Aged | 12 | 2021 | 270681 | 0.08 | Why? |
Infant, Low Birth Weight | 1 | 2008 | 243 | 0.08 | Why? |
Retrospective Studies | 7 | 2018 | 105322 | 0.08 | Why? |
Proportional Hazards Models | 1 | 2018 | 6543 | 0.07 | Why? |
Female | 13 | 2021 | 380317 | 0.07 | Why? |
Disease Management | 2 | 2020 | 6841 | 0.07 | Why? |
Male | 12 | 2021 | 367725 | 0.07 | Why? |
Gastrointestinal Microbiome | 1 | 2017 | 1961 | 0.07 | Why? |
Adult | 11 | 2021 | 244371 | 0.07 | Why? |
Immunologic Factors | 1 | 2020 | 4206 | 0.07 | Why? |
Feces | 1 | 2017 | 4235 | 0.07 | Why? |
Substance Abuse, Intravenous | 1 | 2008 | 411 | 0.06 | Why? |
Evolution, Molecular | 1 | 2017 | 3691 | 0.06 | Why? |
Genetic Variation | 1 | 2017 | 3919 | 0.06 | Why? |
Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.06 | Why? |
Societies, Medical | 1 | 2019 | 6907 | 0.06 | Why? |
Gestational Age | 1 | 2008 | 1488 | 0.06 | Why? |
Cross-Sectional Studies | 3 | 2021 | 53120 | 0.06 | Why? |
Pregnancy Complications, Infectious | 1 | 2008 | 11559 | 0.06 | Why? |
Aged | 8 | 2021 | 215776 | 0.06 | Why? |
Cohort Studies | 3 | 2017 | 36005 | 0.06 | Why? |
Vaccines | 1 | 2021 | 3692 | 0.06 | Why? |
Neutrophils | 1 | 2017 | 5476 | 0.05 | Why? |
Tertiary Care Centers | 1 | 2017 | 8248 | 0.05 | Why? |
Firmicutes | 1 | 2017 | 41 | 0.04 | Why? |
Fusarium | 1 | 2017 | 44 | 0.04 | Why? |
Time Factors | 2 | 2020 | 31397 | 0.04 | Why? |
Mucositis | 1 | 2017 | 40 | 0.04 | Why? |
Actinobacteria | 1 | 2017 | 87 | 0.04 | Why? |
Respiratory Tract Infections | 1 | 2018 | 6817 | 0.04 | Why? |
Viral Load | 1 | 2017 | 15850 | 0.04 | Why? |
Cell- and Tissue-Based Therapy | 1 | 2020 | 422 | 0.04 | Why? |
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3633 | 0.04 | Why? |
Body Mass Index | 1 | 2008 | 4306 | 0.04 | Why? |
Risk Factors | 2 | 2018 | 71621 | 0.03 | Why? |
Aspergillus | 1 | 2017 | 347 | 0.03 | Why? |
RNA, Ribosomal, 16S | 1 | 2017 | 793 | 0.03 | Why? |
Cancer Survivors | 1 | 2021 | 588 | 0.03 | Why? |
Aspergillosis | 1 | 2017 | 264 | 0.03 | Why? |
Textiles | 1 | 2019 | 458 | 0.03 | Why? |
Young Adult | 3 | 2018 | 93724 | 0.03 | Why? |
Candida | 1 | 2017 | 425 | 0.03 | Why? |
Aged, 80 and over | 2 | 2021 | 88759 | 0.03 | Why? |
Receptors, Antigen, T-Cell | 1 | 2017 | 760 | 0.03 | Why? |
Spatio-Temporal Analysis | 1 | 2017 | 1182 | 0.03 | Why? |
Regression Analysis | 1 | 2018 | 2484 | 0.03 | Why? |
Surveys and Questionnaires | 1 | 2017 | 43792 | 0.02 | Why? |
Equipment Contamination | 1 | 2019 | 1308 | 0.02 | Why? |
Cancer Care Facilities | 1 | 2018 | 1190 | 0.02 | Why? |
Kinetics | 1 | 2017 | 3238 | 0.02 | Why? |
Sequence Analysis, DNA | 1 | 2017 | 2830 | 0.02 | Why? |
Tissue Donors | 1 | 2017 | 1679 | 0.02 | Why? |
Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
Infant, Newborn | 1 | 2008 | 23105 | 0.02 | Why? |
Bacteria | 1 | 2017 | 1897 | 0.02 | Why? |
DNA, Viral | 1 | 2017 | 2521 | 0.02 | Why? |
Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
Risk Assessment | 2 | 2021 | 25439 | 0.02 | Why? |
Clinical Decision-Making | 1 | 2020 | 3755 | 0.02 | Why? |
Pregnancy | 1 | 2008 | 23879 | 0.02 | Why? |
ROC Curve | 1 | 2017 | 6024 | 0.02 | Why? |
Pandemics | 3 | 2020 | 389249 | 0.02 | Why? |
Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
Medical Oncology | 1 | 2020 | 3826 | 0.02 | Why? |
Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.02 | Why? |
Prospective Studies | 2 | 2017 | 43301 | 0.01 | Why? |
Longitudinal Studies | 1 | 2017 | 9893 | 0.01 | Why? |
Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
Betacoronavirus | 2 | 2020 | 204454 | 0.01 | Why? |
Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
Adolescent | 2 | 2018 | 86841 | 0.01 | Why? |
Mutation | 1 | 2017 | 12376 | 0.01 | Why? |
Practice Guidelines as Topic | 1 | 2021 | 15421 | 0.01 | Why? |
Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
Public Health | 1 | 2021 | 16359 | 0.01 | Why? |
Child, Preschool | 1 | 2018 | 36283 | 0.01 | Why? |
Health Personnel | 1 | 2020 | 29646 | 0.01 | Why? |
Infection Control | 1 | 2019 | 23131 | 0.01 | Why? |
RNA, Viral | 1 | 2017 | 32276 | 0.01 | Why? |
Child | 1 | 2018 | 70012 | 0.01 | Why? |